Literature DB >> 9734386

PPARgamma and colorectal carcinoma: conflicts in a nuclear family.

B Seed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9734386     DOI： 10.1038/1990

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells.

Authors:  Emmelie A Jansson; Alexandra Are; Gediminas Greicius; I-Chun Kuo; Denise Kelly; Velmurugesan Arulampalam; Sven Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

Review 2.  Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions.

Authors:  Annaswamy Raji; Jorge Plutzky
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

3.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

Authors:  Kimihiko Matsusue; Martin Haluzik; Gilles Lambert; Sun-Hee Yim; Oksana Gavrilova; Jerrold M Ward; Bryan Brewer; Marc L Reitman; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

4.  Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor alpha-regulated gene expression.

Authors:  C Qi; Y Zhu; J Pan; A V Yeldandi; M S Rao; N Maeda; V Subbarao; S Pulikuri; T Hashimoto; J K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 5.  Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancer.

Authors:  Matthew R Smith; Philip W Kantoff
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

6.  Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival.

Authors:  Stamatios Theocharis; Costas Giaginis; Aikaterini Parasi; Alexandra Margeli; John Kakisis; Emmanuel Agapitos; Gregorios Kouraklis
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

7.  PPAR gamma signaling exacerbates mammary gland tumor development.

Authors:  Enrique Saez; John Rosenfeld; Antonia Livolsi; Peter Olson; Eleuterio Lombardo; Michael Nelson; Ester Banayo; Robert D Cardiff; Juan Carlos Izpisua-Belmonte; Ronald M Evans
Journal:  Genes Dev       Date:  2004-03-01       Impact factor: 11.361

8.  PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells.

Authors:  William M Wood; Vibha Sharma; Kevin T Bauerle; Laura A Pike; Qiong Zhou; Deborah L Fretwell; Rebecca E Schweppe; Bryan R Haugen
Journal:  PPAR Res       Date:  2011-12-12       Impact factor: 4.964

9.  Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease.

Authors:  Eric Boitier; Jean-Charles Gautier; Ruth Roberts
Journal:  Comp Hepatol       Date:  2003-01-31

10.  Clinical Use of PPARgamma Ligands in Cancer.

Authors:  Jennifer L Hatton; Lisa D Yee
Journal:  PPAR Res       Date:  2008-12-18       Impact factor: 4.964
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.